Adjuvant Docetaxel for Node-Positive Breast Cancer
0
Authors
Miguel Martín
Miguel Martín•Tadeusz Pieńkowski•Charles Vogel
Published
June 1, 2005
Abstract
We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for operable node-positive breast cancer.
